comparemela.com

Latest Breaking News On - Immunisation implementation advisory group - Page 4 : comparemela.com

Māori doctors address the issue of vaccine hesitancy as the Covid-19 vaccination is set to roll out

Māori TV Three experts with a history of challenging an inequitable health system talk to Moana about using science to survive a pandemic. Days before the first Covid-19 vaccinations are expected to begin, three Māori health experts have answered questions about the vaccine and why some people feel anxious about immunisation. They spoke to Moana Maniapoto the host of Māori TV’s current affairs show, Te Ao with Moana. Clinical immunologists Maia Brewerton and Anthony Jordan, as well as GP Rawiri Jansen, agreed that Māori have suffered in the past, and they understand why some may be vaccine hesitant, but said vaccines do offer an important layer of protection against the coronavirus.

Community Scoop » Pfizer And BioNTech Achieve Approval By Medsafe For Their Vaccine Against COVID-19

Press Release – Joint Press Release Pfizer New Zealand and BioNTech today welcomed the drug safety regulator Medsafe in New Zealand granting Provisional Consent for their COVID-19 mRNA vaccine COMIRNATY. Pfizer is the Market Authorisation Holder in New Zealand. The distribution of the … Pfizer and BioNTech Achieve Approval by Medsafe For Their Vaccine Against COVID-19 New Zealand drug safety regulator Medsafe, approves supply of COVID-19 mRNA vaccine COMIRNATY™ to New Zealand. Pfizer & BioNTech are ready to deliver the 1.5 million doses to New Zealand over 2021, allowing for 750,000 New Zealanders to be vaccinated. Pfizer has a robust and reliable distribution network to deliver our vaccine to New Zealanders over 2021.

Helen Petousis-Harris: the vaccine voice of reason for NZ

David White stuff.co.nz Vaccinologist Dr Helen Petousis-Harris breaks down how a Covid-19 vaccine was developed so fast and what will happen next. The long spotted nightmare was almost over. From her holiday Airbnb in France, vaccine expert Helen Petousis-Harris had just talked to Australian media about the final fizzling of Samoa s devastating measles epidemic. But in that same room, in mid-December 2019, she watched a news report about an odd pneumonia emerging in China. A new nightmare was just beginning. The Auckland University vaccinologist had criticised the government for New Zealand’s own measles epidemic, which we exported to Samoa. The Health Ministry had failed to plug immunisation gaps, despite repeated pleas, and a 2017 mumps outbreak that exposed the depletion of public health resources. The epidemic should never have happened, Petousis-Harris said.

Covid 19 coronavirus: Māori to be prioritised for vaccination

Covid 19 coronavirus: Māori to be prioritised for vaccination 20 Jan, 2021 03:07 AM 3 minutes to read The director general of health is set to address issues of the vaccine rollout and calls to tighten New Zealand borders as Covid rages across the globe. Video / Newstalk ZB The director general of health is set to address issues of the vaccine rollout and calls to tighten New Zealand borders as Covid rages across the globe. Video / Newstalk ZB RNZ By Meriana Johnsen of RNZ The National Māori Pandemic group has said the protection of Māori will be at the centre of planning for the Covid-19 vaccine rollout.

Covid-19 vaccines and equity: Some Kiwis may get more effective jabs than others

Covid-19 Response Minister Chris Hipkins speaks to Stuff about the rollout plans for the vaccine. Questions have been raised about whether New Zealanders will have equitable access to Covid-19 vaccines, as different people are likely to receive different jabs, some of which could be less effective than others. The Government has agreed to purchase – pending safety approval from the national medicines regulator Medsafe – four types of Covid-19 vaccines for Kiwis and residents of several Pacific Island nations. Clinical trials for all the vaccines are still ongoing. However, recent studies have indicated the AstraZeneca vaccine, of which the Government has ordered 7.6 million doses, enough to immunise 3.8m people, may be only 62 per cent effective at preventing transmission of the virus.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.